Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Cochlear ( (AU:COH) ) has provided an update.
Cochlear Limited has notified the market of the cessation of 362 service rights (COHAB) after the conditional rights to securities lapsed because their vesting conditions were not met or became incapable of being satisfied as of 19 December 2025. The move represents a routine adjustment to the company’s issued capital structure under its employee or service-related equity arrangements, with limited direct impact on operations but reflecting ongoing governance and compliance around performance-based or conditional securities.
The most recent analyst rating on (AU:COH) stock is a Hold with a A$300.00 price target. To see the full list of analyst forecasts on Cochlear stock, see the AU:COH Stock Forecast page.
More about Cochlear
Cochlear Limited is a global medical device company specializing in implantable hearing solutions, including cochlear implants and related hearing technologies, serving patients with moderate to profound hearing loss worldwide.
Average Trading Volume: 128,471
Technical Sentiment Signal: Hold
Current Market Cap: A$17.06B
See more insights into COH stock on TipRanks’ Stock Analysis page.